BTG ups revenue forecast after royalty payment

BTG, the specialist healthcare company, has increased its revenue estimate for the year ended March 31st 2013 after receiving a final royalty payment from Pfizer in relation to the BeneFIX product.

BTG, the specialist healthcare company, has increased its revenue estimate for the year ended March 31st 2013 after receiving a final royalty payment from Pfizer in relation to the BeneFIX product.

BTG now expects revenue for the period to come in at £190m-£200m rather than £180m-£190m, including total BeneFIX revenue of £14m, following the $22m payment.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
MoneyWeek

MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.